Tissue Repair Ltd (ASX:TRP)

Australia flag Australia · Delayed Price · Currency is AUD
0.1900
-0.0050 (-2.56%)
May 23, 2025, 3:59 PM AEST
-13.64%
Market Cap 11.49M
Revenue (ttm) 2.39M
Net Income (ttm) -4.44M
Shares Out 60.46M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 130,119
Average Volume 53,966
Open 0.1900
Previous Close 0.1950
Day's Range 0.1700 - 0.1900
52-Week Range 0.1700 - 0.5000
Beta 0.40
RSI 23.02
Earnings Date May 28, 2025

About Tissue Repair

Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. It is developing TR-987, including Glucoprime technology for the treatment of chronic wounds, burns, and other complex wounds; and TR Pro+ for aftercare of minimally invasive cosmetic procedures. The company was incorporated in 2012 and is based in Chatswood, Australia. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol TRP
Full Company Profile

Financial Performance

In 2024, Tissue Repair's revenue was 1.79 million, an increase of 84.31% compared to the previous year's 971,655. Losses were -4.14 million, -0.87% less than in 2023.

Financial Statements

News

There is no news available yet.